Study to Assess Efficacy and Safety of Dupilumab in the Treatment of Keloids
Condition: Keloid Intervention: Drug: Dupilumab Sponsors: Beth Israel Deaconess Medical Center; Regeneron Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2021 Category: Research Source Type: clinical trials
Botulinum Toxin Type A Injection to Prevent Keloid Recurrence
Condition: Scar Keloid Interventions: Drug: Botulinum Toxin Type A Injection [Botox]; Drug: 0.9% Sodium Chloride Injection Sponsors: National Cheng-Kung University Hospital; Tainan Hospital, Ministry of Health and Welfare Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2021 Category: Research Source Type: clinical trials